Protagenic Therapeutics, Inc.
PTIX
$0.49
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 12/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | 354.26% | 82.81% | -46.00% | ||
| Total Depreciation and Amortization | 0.00% | 0.00% | -- | ||
| Total Amortization of Deferred Charges | -- | -100.00% | -24.59% | ||
| Total Other Non-Cash Items | -2,993.44% | -103.06% | -- | ||
| Change in Net Operating Assets | 164.20% | -198.37% | 1,108.40% | ||
| Cash from Operations | 63.47% | -19.54% | -11.41% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -100.00% | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -1,933.83% | ||
| Cash from Investing | -- | -100.00% | -1,933.83% | ||
| Total Debt Issued | 100.00% | -119.79% | -81.91% | ||
| Total Debt Repaid | -- | -- | 200.00% | ||
| Issuance of Common Stock | -- | -100.00% | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | 52.58% | ||
| Cash from Financing | 100.00% | -100.35% | 1,155.86% | ||
| Foreign Exchange rate Adjustments | -100.27% | 131.66% | 256.74% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 62.89% | -133.66% | 101.28% | ||